SGHT · Sight Sciences, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-06 | HAYDEN JEREMY B. |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.37 to $5.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 100,015 shares of Common Stock, and (ii) 257,022 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
12,733 |
| 2026-07-06 | Badawi David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.37 to $5.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 1,813,950 shares of Common Stock, and (ii) 168,922 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
7,418 |
| 2026-07-02 | Bauerlein Alison |
Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 192,669 shares of Common Stock, and (ii) 472,040 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
24,184 |
| 2026-07-02 | Rodberg James |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 55,200 shares of Common Stock, and (ii) 168,837 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
6,902 |
| 2026-07-01 | Taylor Brenton |
EVP, Operations & R&D |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.24 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 36,696 shares of Common Stock, and (ii) 228,282 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
2,829 |
| 2026-07-01 | Badawi Paul |
Director, President and CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.24 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 5,572,746 shares of Common Stock, and (ii) 549,726 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
28,684 |
| 2026-06-10 | Encrantz Staffan |
Director, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased in multiple transactions at per share prices ranging from $4.78 to $4.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Includes (i)1,406,022 shares of Common Stock and (ii) 28,261 restricted stock units, which restricted stock units are subject to vesting as previously reported. |
Common Stock
|
14,100 |
| 2026-06-04 | Zurbay Donald |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Includes (i) 75,352 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 90,000 shares of Common Stock which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 4, 2026. |
Common Stock
|
28,261 |
| 2026-06-04 | Mazzacco Catherine |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Includes (i) 30,952 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 10,063 RSUs granted to the Reporting Person on June 8, 2023 which are subject to vesting as previously reported. |
Common Stock
|
28,261 |
| 2026-06-04 | Fountain Tamara |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Includes (i) 81,389 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein. |
Common Stock
|
28,261 |
| 2026-06-04 | Burbach Gerhard F |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Includes (i) 44,922 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 49,844 RSUs granted to the Reporting Person on 5/12/2025 which are subject to vesting as previously reported. |
Common Stock
|
28,261 |
| 2026-06-04 | Encrantz Staffan |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Includes (i)1,391,922 shares of Common Stock and (ii) 28,261 RSUs which are subject to vesting as reported herein. |
Common Stock
|
28,261 |
| 2026-05-18 | Bauerlein Alison |
Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $4.91 to $5.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 169,810 shares of Common Stock, and (ii) 519,083 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
12,728 |
| 2026-04-06 | HAYDEN JEREMY B. |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 87,274 shares of Common Stock, and (ii) 282,496 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
13,761 |
| 2026-04-06 | Rodberg James |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 47,160 shares of Common Stock, and (ii) 183,779 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
7,231 |
| 2026-04-02 | Badawi David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 1,804,359 shares of common stock, and (ii) 185,931 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested. |
Common Stock
|
8,168 |
| 2026-04-02 | Bauerlein Alison |
Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.43 to $3.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 156,788 shares of Common Stock, and (ii) 544,833 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
25,874 |
| 2026-04-01 | Badawi Paul |
Director, President and CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.63 to $3.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 5,544,983 shares of Common Stock, and (ii) 606,173 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
29,244 |
| 2026-04-01 | Taylor Brenton |
EVP, Operations & R&D |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.63 to $3.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 31,631 shares of Common Stock, and (ii) 236,176 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
2,869 |
| 2026-02-19 | Badawi David |
Director, Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects the exercise of stock options ("Options") awarded to the Reporting Person under the Issuer's equity incentive plan. Includes (i) 1,795,520 shares of common stock, and (ii) 202,938 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units that have not yet vested. |
Common Stock
|
21,270 |
| 2026-02-19 | Badawi David |
Director, Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects the exercise of stock options ("Options") awarded to the Reporting Person under the Issuer's equity incentive plan. The grant of Options made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options became fully vested and exercisable on January 1, 2020. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-02-03 | Badawi David |
Director, Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $420,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. Includes (i) 1,774,250 shares of Common Stock, and (ii) 202,938 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
64,915 |
| 2026-02-03 | HAYDEN JEREMY B. |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $750,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. Includes (i) 75,562 shares of Common Stock, and (ii) 307,969 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
115,920 |
| 2026-02-03 | Badawi Paul |
Director, President and CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $1,000,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. Includes (i) 5,517,778 shares of Common Stock, and (ii) 662,622 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
154,560 |
| 2026-02-03 | Rodberg James |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $562,500 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. Includes (i) 39,451 shares of Common Stock, and (ii) 198,719 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
86,940 |
| 2026-02-03 | Bauerlein Alison |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $825,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. Includes (i) 135,620 shares of Common Stock, and (ii) 591,875 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
127,512 |
| 2026-02-03 | Taylor Brenton |
EVP, Operations & R&D |
Award↑
Filing footnotes — Common Stock (Direct)
Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2026 and continuing through December 31, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $650,000 divided by the closing price of the Common Stock on the grant date, which was February 3, 2026. Includes (i) 26,606 shares of Common Stock, and (ii) 244,070 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested. |
Common Stock
|
100,464 |
| 2026-01-16 | Badawi David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("common stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of common stock were sold. The shares were sold in multiple transactions at prices ranging from $6.44 to $6.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 1,774,250 shares of common stock, and (ii) 138,023 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested. |
Common Stock
|
4,836 |
| 2026-01-16 | Rodberg James |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("common stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of common stock were sold. The shares were sold in multiple transactions at prices ranging from $6.44 to $6.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 39,451 shares of common stock, and (ii) 111,779 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested. |
Common Stock
|
2,616 |
| 2026-01-16 | HAYDEN JEREMY B. |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("common stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of common stock were sold. The shares were sold in multiple transactions at prices ranging from $6.44 to $6.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 75,562 shares of common stock, and (ii) 192,049 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested. The Reporting Person previously reported a grant of 12,000 RSUs on a Form 4 filed on February 11, 2022 (which was subsequently included under Table 1 on a Form 4 filed on January 5, 2023) and a grant of 45,100 RSUs on a Form 4 filed on March 21, 2023, which were awarded on February 9, 2022 and March 16, 2023, respectively. Of these RSU grants, 39,825 shares were inadvertently excluded from the Reporting Person's beneficially owned shares. The reported balance includes these previously excluded shares. Furthermore, the Reporting Person's Form 4 filed on February 16, 2024 inadvertently included under Column 5 of Table I 11,326 shares of common stock underlying the Reporting Person's stock options that were to vest within 60 days of the date of such filing. The reported balance on this Form 4 excludes the number of shares underlying such stock options. |
Common Stock
|
6,308 |
| 2026-01-16 | Badawi Paul |
Director, President and CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share ("common stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of common stock were sold. The shares were sold in multiple transactions at prices ranging from $6.44 to $6.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 5,517,778 shares of common stock, and (ii) 508,062 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested. The Reporting Person previously reported a grant of 87,800 RSUs on a Form 4 filed on February 11, 2022 (which was subsequently included under Table 1 on a Form 4 filed on January 5, 2023) and a grant of 176,600 RSUs on a Form 4 filed on March 21, 2023, which were awarded on February 9, 2022 and March 16, 2023, respectively. Of these RSU grants, 176,500 shares were inadvertently excluded from the Reporting Person's beneficially owned shares. The reported balance includes these previously excluded shares. Furthermore, the Reporting Person's Form 4 filed on February 16, 2024 inadvertently included under Column 5 of Table I 53,574 shares of common stock underlying the Reporting Person's stock options that were to vest within 60 days of the date of such filing. The reported balance on this Form 4 excludes the number of shares underlying such stock options. |
Common Stock
|
22,362 |
| 2026-01-06 | Rodberg James |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
594 |
| 2026-01-06 | Badawi David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,695 |
| 2026-01-06 | Bauerlein Alison |
Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
9,647 |
| 2026-01-06 | HAYDEN JEREMY B. |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
1,785 |
| 2026-01-06 | Badawi Paul |
Director, President and CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
11,870 |
| 2026-01-06 | Taylor Brenton |
EVP, Operations & R&D |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.39 to $7.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
619 |
| 2026-01-05 | Badawi David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
3,051 |
| 2026-01-05 | Rodberg James |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
4,405 |
| 2026-01-05 | Bauerlein Alison |
Chief Operating Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
10,896 |
| 2026-01-05 | HAYDEN JEREMY B. |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.71 to $7.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
9,385 |
| 2026-01-02 | Badawi David |
Director, Chief Technology Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.29 to $8.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
2,914 |
| 2026-01-02 | Badawi Paul |
Director, President and CEO, 10% Owner |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $7.29 to $8.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
25,356 |
| 2025-12-26 | Badawi David |
Director, Chief Technology Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan. The grant of stock options ("Options") made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on January 1, 2020. |
Stock Option (Right to Buy)
|
21,270 |
| 2025-12-26 | Badawi David |
Director, Chief Technology Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan. Includes (i) 1,758,996 shares of common stock, and (ii) 167,773 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested. The Reporting Person previously reported a grant of 28,100 RSUs on a Form 4 filed on February 11, 2022 (which was subsequently included under Table 1 on a Form 4 filed on January 5, 2023) and a grant of 39,100 RSUs on a Form 4 filed on March 21, 2023, which were awarded on February 9, 2022 and March 16, 2023, respectively. Of these RSU grants, 43,375 shares were inadvertently excluded from the Reporting Person's beneficially owned shares. The reported balance includes these previously excluded shares. |
Common Stock
|
21,270 |
| 2025-12-16 | Encrantz Staffan |
Director, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased in multiple transactions at per share prices ranging from $8.12 to $8.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Includes (i)1,360,970 shares of Common Stock and (ii) 30,952 restricted stock units which are subject to vesting as previously reported. |
Common Stock
|
13,958 |
| 2025-12-02 | Rodberg James |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.16 to $8.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
2,518 |
| 2025-11-25 | HAYDEN JEREMY B. |
Chief Legal Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse. The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions. The options are fully vested and exercisable. |
Stock Option (Right to Buy)
|
37,560 |
| 2025-11-25 | HAYDEN JEREMY B. |
Chief Legal Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse. The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions. Reflects the exercise of stock options awarded to the Reporting Person under the Issuer's equity incentive plan. |
Common Stock
|
7,290 |
| 2025-11-25 | HAYDEN JEREMY B. |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in connection with, and pursuant to, the terms of a marital separation agreement previously entered into between the Reporting Person and his former spouse. The Reporting Person's spouse will receive all proceeds from the shares sold in the transactions. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Common Stock
|
44,850 |